The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?

被引：59
作者：
Lakhani, Sunil R. [1 ]
Audretsch, Werner
Cleton-Jensen, Anne-Marie
Cutuli, Bruno
Ellis, Ian
Eusebi, Vincenzo
Greco, Marco
Houslton, Richard S.
Kuhl, Christiane K.
Kurtz, John
Palacios, Jose
Peterse, Hans
Rochard, France
Rutgers, E.
机构：
[1] Univ Queensland, Mayne Med Sch, Sch Med, Brisbane, Qld 4006, Australia
[2] Klin Landeshauptstadt Dusseldorf gGmbH, Interdisciplinary Breast Ctr, D-40625 Dusseldorf, Germany
[3] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
[4] Polyclin Courlancy, Dept Radiat Oncol, F-51100 Reims, France
[5] Univ Nottingham, City Hosp, Dept Histopathol, Nottingham NG5 1PB, England
[6] Univ Bologna, Dept Pathol M Malpighi, Bologna, Italy
[7] Ist Nazl Tumori, Breast Unit, I-20133 Milan, Italy
[8] Inst Canc Res, Sect Canc Genet, Surrey, England
[9] Univ Bonn, Dept Radiol & Radiat Therapy, Sect Oncol Imaging, D-53105 Bonn, Germany
[10] Spanish Natl Canc Ctr, Mol Pathol Programme, Breast & Gynaecol Canc Grp, Madrid, Spain
[11] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[12] Inst Gustave Roussy, F-94805 Villejuif, France
[13] Netherlands Canc Inst, Dept Surg, NL-1066 Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2006年 / 42卷 / 14期
关键词：
D O I：
10.1016/j.ejca.2006.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lobular carcinoma in situ was first described over 60 years ago. Despite the long history, it continues to pose significant difficulties in screening, diagnosis, management and treatment. This is partly due its multi-focal and bilateral presentation, an incomplete understanding of its biology and natural history and perpetuation of misconceptions gathered over the last decades. In this review, the working group on behalf of EUSOMA has attempted to summarise the current thinking and management of this interesting lesion. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2205 / 2211
页数：7
相关论文
共 78 条
[1]  
Abner AL, 2000, CANCER, V88, P1072, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1072::AID-CNCR18>3.0.CO
[2]  
2-D
[3]  
ANDERSEN JA, 1974, ACTA PATH MICRO IM A, VA 82, P519
[4]  
ANDERSEN JA, 1977, CANCER, V39, P2597, DOI 10.1002/1097-0142(197706)39:6<2597::AID-CNCR2820390644>3.0.CO
[5]  
2-E
[6]  
Bentz JS, 1998, MODERN PATHOL, V11, P814
[7]   Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy [J].
Berg, WA ;
Mrose, HE ;
Ioffe, OB .
RADIOLOGY, 2001, 218 (02) :503-509
[8]  
Berx G, 1996, ONCOGENE, V13, P1919
[9]   E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers [J].
Berx, G ;
CletonJansen, AM ;
Nollet, F ;
deLeeuw, WJF ;
vandeVijver, MJ ;
Cornelisse, C ;
vanRoy, F .
EMBO JOURNAL, 1995, 14 (24) :6107-6115
[10]   Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias [J].
Bratthauer, GL ;
Moinfar, F ;
Stamatakos, MD ;
Mezzetti, TP ;
Shekitka, KM ;
Man, YG ;
Tavassoli, FA .
HUMAN PATHOLOGY, 2002, 33 (06) :620-627
12345678